CITES Clause Samples

POPULAR SAMPLE Copied 1 times
CITES. In addition to the MMPA restrictions on import and export discussed above, CITES provisions that apply to the polar bear also ensure that import into or export from the United States is carefully regulated. Under CITES and the U.S. regulations that implement CITES at 50 CFR part 23, the United States is required to regulate and monitor the trade in legally possessed CITES specimens over an international border. Thus, for example, CITES would apply to tourists driving from Alaska through Canada with polar bear handicrafts to a destination elsewhere in the United States. As an Appendix II species, the export of any polar bear, either live or dead, and any polar bear parts or products requires an export permit supported by a finding that the specimen was legally acquired under international and domestic laws. Prior to issuance of the permit, the exporting country must also find that export will not be detrimental to the survival of the species. A valid export document issued by the exporting country must be presented to the officials of the importing country before the polar bear specimen will be cleared for importation. Some limited exceptions to this permit requirement exist. For example, consistent with CITES, the United States provides an exemption from the permitting requirements for personal and household effects made of dead specimens. Personal and household effects must be personally owned for noncommercial purposes, and the quantity must be necessary or appropriate for the nature of the trip or stay or for household use. Not all CITES countries have adopted this exemption, so persons who may cross an international border with a polar bear specimen should check with the Service and the country of transit or destination in advance as to applicable requirements. Because, for polar bears, any person importing or exporting any live or dead animal, part, or product into or from the United States must comply with the strict provisions of CITES as well as the strict import and export provisions under the MMPA, we find that additional authorizations under the ESA to engage in these activities would not be necessary and advisable to provide for the conservation of the species. The Secretary has the discretion to prohibit by regulation with respect to polar bears any act prohibited in Section 9(a)(1) of the ESA. Thus, under Alternative 2 (this proposed 4(d) special rule, Alternative 3, and Alternative 4), if an import or export activity is authorized or exempte...
CITES. Where the Deliverables (or any of the materials which the Supplier intends to bring onto the Premises) consist of or contain plant and/or fungi materials derived from species listed in the 1975 Convention on International Trade in Endangered Species (CITES) such plant and/or fungi material shall be compliant with CITES and national laws and regulations and relevant EU regulations when dealing with Northern Ireland for implementing CITES. The Supplier must shall, on request, provide Kew with copies of any certificates, permits, documents or other information relating to the Deliverables that Kew may reasonably require and that demonstrate compliance with CITES.
CITES. The U.S., along with 180 other countries, is a party to the Convention on International Trade in Endangered Species (CITES). CITES is a multilateral treaty aimed at preventing the extinction of listed species of wild animals and plants by regulating the international trade in those listed species. There are three appendices of CITES-listed species. Relevant to this matter, Appendix III species are those that are listed after a member country petitions the other CITES parties for assistance in controlling trade in the species.
CITES the appendix on which the species is listed is shown. EU: the annex from trade regulations 338/97 and 407/2009 on which the species is listed is shown. Table 1: Status of waterbird species listed in the AEWA Action Plan against trade regulations. AEWA CITES EU Spheniscus demersus A 1b; B 2a 2c II B Pelecanus crispus* A 1a 1c I A Ciconia nigra A 1c 2 II A Balaeniceps ▇▇▇ A 1c II B Geronticus ▇▇▇▇▇▇▇* A 1a 1b 1c I A Platalea leucorodia A 1c 2 II A Phoenicopterus ruber A 3a; B 2a II A Phoenicopterus minor A 2 3a; B 2a 2c II Oxyura leucocephala* A 1a 1b 1c II A Branta ruficollis* A 1a 1b 3a 3c II A Sarkidiornis melanotos B 1; C 1 II B Balearica pavonina A 2 3c II Balearica regulorum A 1c II Grus virgo A 1c; B 1 II Grus paradisea A 1b; B 1 II Grus carunculatus A 1b 1c II Grus grus A 1c 3c; B 1; C 1 II A Grus leucogeranus* A 1a 1b 1c I A Numenius tenuirostris* A 1a 1b 1c I A *Species also listed on Appendix I of the Convention on the Conservation of Migratory Species of Wild Animals (CMS) 1 There are no Annex D waterbird species applicable to the AEWA area. 2 Species also listed on Appendix 1 to the Bonn Convention. The occurrence of globally threatened species of migratory waterbirds in AEWA Range States, based on the 2010 IUCN Red List of Threatened Species and their status under CITES15. Breeding species are indicated with a ‘B’; species occurring only as passage migrants and winter visitors are indicated with a ‘W’. No attempt has been made to indicate relative numbers, and in some instances, the numbers of birds involved may be very small. Codes followed by an asterisk * mark species not included in Threatened Birds of the World 16 but known nevertheless to occur in the country. Sociable Lapwing Slender-billed Curlew Northern Bald Ibis Siberian Crane White-headed Duck Red-breasted Goose Bank Cormorant Madagascar Pond-Heron White-winged Flufftail African Penguin Lesser White-fronted Goose Dalmatian Pelican Cape Gannet Socotra Cormorant Slaty Egret Shoebill Marbled Teal ▇▇▇▇▇▇▇’▇ ▇▇▇▇▇ Blue ▇▇▇▇▇ Wattled Crane Black Crowned Crane Grey Crowned Crane Madagascar Pratincole Great Knot Total Number of species Red List Status CR CR CR CR EN EN EN EN EN EN ▇▇ ▇▇ ▇▇ ▇▇ ▇▇ ▇▇ ▇▇ ▇▇ ▇▇ ▇▇ ▇▇ ▇▇ ▇▇ ▇▇ CITES-listed17 no yes yes yes yes yes no no no yes no yes no no no yes no no yes yes yes yes no no Albania B/W 1 Algeria W B B 3 Angola B 1 Armenia B B 2 Azerbaijan W W W B 4 Bahrain B 1 Benin B/W 1 Botswana B B 2 Bulgaria W W W W B/W 5 Burkina Faso B/W 1 Burundi W B 2 Cam...

Related to CITES

  • Denial If NB denies the Applicant, NB shall furnish a written statement stating its reasons. The Applicant shall have the opportunity to discuss the decision with the Director of Social Services. The Applicant has the right to an administrative fair hearing. If NB denies an Applicant based in part on an indicated child abuse or maltreatment report, the Applicant has a right to a fair hearing regarding the report. The request must be made within 90 days of receiving the written denial notice. (See Disclosures, page 10.)

  • COMPLAINTS HANDLING 44.1 Either Party shall notify the other Party of any Complaints made by Other Contracting Bodies, which are not resolved by operation of the Supplier's usual complaints handling procedure within five (5) Working Days of becoming aware of that Complaint and, if the Supplier is the Party providing the notice, such notice shall contain full details of the Supplier's plans to resolve such Complaint. 44.2 Without prejudice to any rights and remedies that a complainant may have at Law (including under this Framework Agreement and/or a Call Off Agreement), and without prejudice to any obligation of the Supplier to take remedial action under the provisions of this Framework Agreement and/or a Call Off Agreement, the Supplier shall use its all reasonable endeavours to resolve the Complaint within ten (10) Working Days and in so doing, shall deal with the Complaint fully, expeditiously and fairly. 44.3 Within two (2) Working Days of a request by the Authority, the Supplier shall provide full details of a Complaint to the Authority, including details of steps taken to achieve its resolution.

  • How to File an Appeal of a Prescription Drug Denial For denials of a prescription drug claim based on our determination that the service was not medically necessary or appropriate, or that the service was experimental or investigational, you may request an appeal without first submitting a request for reconsideration. You or your physician may file a written or verbal prescription drug appeal with our pharmacy benefits manager (PBM). The prescription drug appeal must be submitted to us within one hundred and eighty (180) calendar days of the initial determination letter. You will receive written notification of our determination within thirty (30) calendar days from the receipt of your appeal. Your appeal may require immediate action if a delay in treatment could seriously jeopardize your health or your ability to regain maximum function, or would cause you severe pain. To request an expedited appeal of a denial related to services that have not yet been rendered (a preauthorization review) or for on-going services (a concurrent review), you or your healthcare provider should call: • our Grievance and Appeals Unit; or • our pharmacy benefits manager for a prescription drug appeal. Please see Section 9 for contact information. You will be notified of our decision no later than seventy-two (72) hours after our receipt of the request. You may not request an expedited review of covered healthcare services already received.

  • Errors, Questions, and Complaints a. In case of errors or questions about your transactions, you should as soon as possible contact us as set forth in Section 6 of the General Terms above. b. If you think your periodic statement for your account is incorrect or you need more information about a transaction listed in the periodic statement for your account, we must hear from you no later than sixty (60) days after we send you the applicable periodic statement for your account that identifies the error. You must: 1. Tell us your name; 2. Describe the error or the transaction in question, and explain as clearly as possible why you believe it is an error or why you need more information; and, 3. Tell us the dollar amount of the suspected error. c. If you tell us orally, we may require that you send your complaint in writing within ten (10) Business Days after your oral notification. Except as described below, we will determine whether an error occurred within ten (10) Business Days after you notify us of the error. We will tell you the results of our investigation within three (3) Business Days after we complete our investigation of the error, and will correct any error promptly. However, if we require more time to confirm the nature of your complaint or question, we reserve the right to take up to forty-five (45) days to complete our investigation. If we decide to do this, we will provisionally credit your Eligible Transaction Account within ten (10) Business Days for the amount you think is in error. If we ask you to submit your complaint or question in writing and we do not receive it within ten (10) Business Days, we may not provisionally credit your Eligible Transaction Account. If it is determined there was no error we will mail you a written explanation within three (3) Business Days after completion of our investigation. You may ask for copies of documents used in our investigation. We may revoke any provisional credit provided to you if we find an error did not occur.

  • Grievability Denial of a petition for reinstatement is grievable. The grievance may not be based on information other than that shared with the Employer at the time of the petition for reinstatement.